Quality Assurance
FDA Update on ICH E6, E8, QbD and RBM in Clinical Trials
Posted in: Quality Assurance, Thought Leadership
Integrating Quality by Design (QbD) and Risk-Based Monitoring (RBM) approaches in clinical […]
Read More....Revolutionizing Clinical Trials: The Power And Potential Of Risk-Based Monitoring
The article explores the benefits and misconceptions of risk-based monitoring (RBM) in […]
Read More....The Fallacy of the Corporate Memory Concept
The article challenges the concept of “corporate memory” within large CROs, arguing […]
Read More....Keys to Successful Risk Management in Clinical Trials
The article emphasizes the critical role of comprehensive risk management in clinical […]
Read More....Shifting the Approach: 4 Strategies for ICH E6(R3) Implementation
Posted in: Quality Assurance, Thought Leadership
Implementing the ICH E6(R3) guidelines requires organizations to adopt a proportionate approach […]
Read More....Gap Analysis and Collaboration Lead to Success
Conducting a comprehensive gap analysis and fostering collaboration within your organization’s quality […]
Read More....